Compass Therapeutics, Inc. CMPX

Updated: 18 Jun 2026

NASDAQ | Biotech | Oncology antibody therapeutics

No signal published yet

We already track Compass Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Compass Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Oncology antibody therapeutics
We're already tracking Compass Therapeutics, Inc. — here are the latest events we've registered

Recent News

  • On June 4, 2026, the company presented Phase 1 clinical data for CTX-8371 at the ASCO Annual Meeting, demonstrating early activity in patients with advanced malignancies. Compass also announced plans to meet with the FDA in August 2026 to discuss the registrational path for its lead candidate, tovecimig.

What Firelda Watch includes for Compass Therapeutics, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Compass Therapeutics, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Want to follow Compass Therapeutics, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Compass Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Compass Therapeutics, Inc. CMPX
Compass Therapeutics — follow and we'll monitor it
Follow Compass Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.